Allergan plc (NYSE: AGN), which is all set to be acquired by rival drugmaker AbbVie (ABBV), reported a 21% increase in fourth-quarter
Allergan plc.
-(AGN)
XNYS:AGN
Allergan (NYSE: AGN) Q3 loss widens but beats estimates
Allergan plc (NYSE: AGN) reported a wider loss in the third quarter of 2019 due to the divestitures, products that lost or
Allergan (AGN) Q3 earnings preview: Patent issues, AbbVie deal in focus
After securing shareholders' approval for the takeover deal with AbbVie (ABBV), Allergan (NYSE: AGN) will be publishing its third-quarter results on November
Will Allergan-AbbVie merger be intercepted
Allergan plc (NYSE: AGN) continued to dominate in the tissue expander market as the demand for plastic surgeries is increasing from the
M&A alert: AbbVie agrees to acquire Allergan for $63 billion
Confirming reports published by Wall Street Journal earlier today, pharmaceutical giant Abbvie (NYSE: ABBV) said it would acquire Irish competitor Allergan (NYSE:
Intercept Pharmaceuticals reports mixed Q1 results
Intercept Pharmaceuticals (NASDAQ: ICPT) reported wider-than-expected losses in the first quarter of 2019, primarily due to higher R&D expenses related to NASH
Allergan beats estimates on Q1 results, raises full-year guidance
Allergan plc (NYSE: AGN) topped market forecasts on revenue and earnings for the first quarter of 2019. Despite the beat, shares fell
Earnings preview: What to expect when Allergan reports Q1 2019 earnings results
Allergan plc (NYSE: AGN) is scheduled to report earnings results for the first quarter of 2019 on Tuesday, May 7, before market
Calendar: Earnings of AIG, Electronic Arts, Walt Disney, Cronos Group, Dropbox, GoPro in lineup
AIG, Electronic Arts, Walt Disney, Cronos Group, Dropbox, GoPro, and more earnings are scheduled for the week between May 6 and 10.
What is NASH and which biotech firms are vying for the first-mover status
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards this liver disorder is
Axsome Therapeutics stock climbs to 34-month high
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of
Allergan’s stock falls after company reports loss in Q4
Allergan plc (AGN) saw its shares drop 4.2% in premarket hours on Tuesday after the company reported a GAAP net loss for
Earnings preview: Botox to drive Allergan’s growth in Q4
Allergan plc (AGN) is set to report its fourth-quarter 2018 earnings results on Tuesday, January 29, before market open. Analysts expect earnings
Amgen set to report Q4 earnings on Jan. 29. What’s in store?
Amgen (AMGN) will be reporting its fourth quarter and full-year 2018 earnings results on Tuesday, January 29 after market closes. Analysts expect
Earnings Preview: All eyes on the Pfizer-Glaxo JV
Pfizer Inc. (PFE) is scheduled to report earnings results for the fourth quarter of 2018 on Tuesday, January 29, before market open.
Allergan stock plunges to 5-year low after product recall in Europe
Allergan (AGN) suffered a major setback Wednesday after European regulators asked the company to stop the sale of its textured breast implants
Allergan, Mylan and other generics beam as Pfizer loses patent war in the UK
It was good news for generic drug firms such as Allergan (AGN) and Mylan (MYL), as pharma giant Pfizer (PFE) lost a